Publications by authors named "Sehrish Afzal"
Article Synopsis
- Diabetes mellitus (DM) is a growing global health issue associated with multiple health risks, and vildagliptin is a commonly used medication for managing high blood sugar in diabetic patients.
- The study focused on creating zinc oxide nanoparticles (ZnO NPs) to enhance the effectiveness and reduce side effects of vildagliptin by improving drug retention and hypoglycemic effects.
- Various characterization methods confirmed the successful synthesis of vildagliptin-loaded ZnO NPs, with in vitro testing showing strong inhibition rates of α-amylase and DPP IV enzymes, suggesting enhanced anti-diabetic activity.
